Google DeepMind Enhances AMIE for Long-Term Disease ManagementGoogle DeepMind's AMIE now supports longitudinal disease management using a two-agent model for enhanced patient care.
Experts Argue It's Time for Obesity to Be Defined Beyond BMIBMI is an imperfect tool indicating obesity and should be replaced or supplemented with better metrics.Obesity can be categorized into clinical and preclinical to improve diagnosis and treatment.A new framework for obesity diagnosis offers a more objective and globally applicable method.
Redefining Obesity With New Global Guidelines - News CenterNew guidelines aim to redefine obesity diagnosis beyond BMI, utilizing objective health measures.Two new categories, clinical and pre-clinical obesity, assist in better categorizing obesity-related health risks.Emphasis on stigma-free treatment approaches for all individuals living with obesity.
Experts Argue It's Time for Obesity to Be Defined Beyond BMIBMI is an imperfect tool indicating obesity and should be replaced or supplemented with better metrics.Obesity can be categorized into clinical and preclinical to improve diagnosis and treatment.A new framework for obesity diagnosis offers a more objective and globally applicable method.
Redefining Obesity With New Global Guidelines - News CenterNew guidelines aim to redefine obesity diagnosis beyond BMI, utilizing objective health measures.Two new categories, clinical and pre-clinical obesity, assist in better categorizing obesity-related health risks.Emphasis on stigma-free treatment approaches for all individuals living with obesity.
New blood tests can help diagnose Alzheimer's. Are doctors ready for what's next?Blood tests are revolutionizing Alzheimer's diagnosis, aiding in early detection and treatment decisions.